Clinical Trial Update: A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02) [Phase 3]

View source ↗

Summary

Phase III open-label, randomized study evaluating VBI-S for treatment of hypovolemia in patients with septic shock; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypovolemia
• Sepsis
• Septic Shock

Drugs mentioned

• VBI-S

Snippet

Sponsor: Vivacelle Bio | Conditions: Septic Shock, Sepsis | Phase 3 | Status: RECRUITING